Imagion Biosystems Ltd. (AU:IBX) has released an update.
Imagion Biosystems Limited has notified the ASX of a change in Director Mark Gerald Van Asten’s interest due to a share consolidation, which has reduced his holding to 15,329 Ordinary Shares and a smaller number of Unlisted Performance Options. The consolidation, approved at the company’s Extraordinary General Meeting on November 13, 2023, converted every forty securities into one. No other transactions, such as acquisitions or disposals of securities, were reported in this notice.
For further insights into AU:IBX stock, check out TipRanks’ Stock Analysis page.
